XDx Hopes 510(k) For Heart Transplant Rejection Test Will Aid Reimbursement

Molecular diagnostics firm XDx expects 510(k) clearance for its AlloMap HTx heart transplant rejection test, previously available as a laboratory home-brew, will lead to better reimbursement and market adoption

More from Archive

More from Medtech Insight